Multimedia Release -- New 3-Minute Screen for Depression, Anxiety, Bipolar Disorder, PTSD Provides ONE Number to Show ...

BETHESDA, Md. -- Getting the answer to a simple question -- "Whats My M3" -- gives you a number to help you and your primary care physician better understand and manage your overall health. WhatsMyM3 ...

Dainippon Sumitomo Pharma Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase ...

Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression .